Grade My Investments

Baxter International Inc. (BAX) Stock Grade

BAX · Healthcare

C+
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$12.1B
P/E Ratio
—
Revenue Growth (YoY)
+5.7%
Net Margin
-8.5%
Return on Equity
—
Dividend Yield
1.9%

About Baxter International Inc.'s fundamentals

Baxter International is a $12.1 billion healthcare company in the medical instruments and supplies sector with revenue growing 5.7% year-over-year. Despite reporting a net loss with a negative 8.5% net margin in its latest annual statement, the company generated positive free cash flow, indicating operational cash generation despite accounting losses. The company offers shareholders a 1.9% dividend yield. The inability to calculate standard profitability metrics like P/E ratio and return on equity reflects the company's current unprofitable position on a net income basis.

Track BAX free — no credit card required. Live grade + monthly AI report →